Influence of steroid hormones on ventricular repolarization-Reference-Cited by-同舟云学术

Influence of steroid hormones on ventricular repolarization

Published:2016-11 Issue: Volume:167 Page:38-47
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Salem Joe-Elie,Alexandre Joachim,Bachelot Anne,Funck-Brentano Christian

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference101 articles.

1. Complex influence of gonadotropins and sex steroid hormones on QT interval duration;Abehsira;J Clin Endocrinol Metab,2016

2. Rabbit ventricular myocardium undergoing simulated ischemia and reperfusion in a double compartment tissue bath: a model to investigate both antiarrhythmic and arrhythmogenic likelihood;Alexandre;Int J Physiol Pathophysiol Pharmacol,2013

3. Proarrhythmic effects of aldosterone during myocardial ischemia–reperfusion: implication of the sarcolemmal-KATP channels;Alexandre;J Cardiovasc Pharmacol,2014

4. Aldosterone and testosterone: two steroid hormones structurally related but with opposite electrophysiological properties during myocardial ischemia–reperfusion;Alexandre;Fundam Clin Pharmacol,2015

5. The effect of chronic anabolic-androgenic steroid use on Tp-E interval, Tp-E/Qt ratio, and Tp-E/Qtc ratio in male bodybuilders;Alizade;Ann Noninvasive Electrocardiol,2015

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Obesity on Repolarization and Other ECG Parameters;Journal of Clinical Medicine;2024-06-19

2. Impaired Cardiac AMPK (5′‐Adenosine Monophosphate‐Activated Protein Kinase) and Ca ²⁺ ‐Handling, and Action Potential Duration Heterogeneity in Ibrutinib‐Induced Ventricular Arrhythmia Vulnerability;Journal of the American Heart Association;2024-06-18

3. Cardiovascular complications of ribociclib in breast cancer patients;Critical Reviews in Oncology/Hematology;2024-04

4. A real-world pharmacovigilance study of QT interval prolongation and Torsades de Pointes associated with CDK4/6 inhibitors in breast cancer patients: findings from the FDA adverse event reporting system;Expert Opinion on Drug Safety;2024-03-14

5. Cardiovascular disease burden in patients with urological cancers: The new discipline of uro‐cardio‐oncology;Cancer Innovation;2024-02-05